Expression Therapeutics

    OverviewSuggest Edit

    Expression Therapeutics is a biotechnology company providing products for hemophilia care. It develops gene therapies for hemophilia A and B, neuroblastoma, T-cell leukemia/lymphoma, acute myeloid leukemia, and hematologic disorders such as hemophagocytic lymphohistiocytosis.
    TypePrivate
    Founded2008
    HQTucker, GA, US
    Websiteexpressiontherapeutics.com

    Latest Updates

    Employees (est.) (Jul 2021)14
    Cybersecurity ratingBMore

    Key People/Management at Expression Therapeutics

    Mohan Rao

    Mohan Rao

    Chief Executive Officer
    H. Trent Spencer

    H. Trent Spencer

    President
    Gabriela Denning

    Gabriela Denning

    Vice President of Research & Development
    Christopher B. Doering

    Christopher B. Doering

    Chief Scientific Officer
    William Swaney

    William Swaney

    Vice President, Manufacturing
    Show more

    Expression Therapeutics Office Locations

    Expression Therapeutics has an office in Tucker
    Tucker, GA, US (HQ)
    1860 Montreal Rd
    Show all (1)

    Expression Therapeutics Financials and Metrics

    Summary Metrics

    Founding Date

    2008

    Expression Therapeutics Cybersecurity Score

    Cybersecurity ratingPremium dataset

    B

    89/100

    SecurityScorecard logo

    Expression Therapeutics Online and Social Media Presence

    Embed Graph

    Expression Therapeutics News and Updates

    Expression Therapeutics Announces Success in Developing a Stem Cell Lentiviral Gene Therapy for Hemophagocytic Lymphohistiocytosis (HLH)

    ATLANTA, Aug. 24, 2020 /PRNewswire/ -- Primary HLH is a family of devastating primary immune deficiencies with limited treatment options and no gene therapies under clinical testing. Expression Therapeutics has developed a promising and potentially curative gene therapy candidate for...

    Expression Therapeutics Announces IND Approval by the FDA for Hemophilia A Gene Therapy

    ATLANTA, May 26, 2020 /PRNewswire/ -- Expression Therapeutics has announced that it has received clearance by the United States Food and Drug Administration (FDA) to proceed following review of its Investigational New Drug Application (IND) for clinical testing of its novel lentiviral...

    Expression Therapeutics Frequently Asked Questions

    • When was Expression Therapeutics founded?

      Expression Therapeutics was founded in 2008.

    • Who are Expression Therapeutics key executives?

      Expression Therapeutics's key executives are Mohan Rao, H. Trent Spencer and Gabriela Denning.

    • How many employees does Expression Therapeutics have?

      Expression Therapeutics has 14 employees.

    • Who are Expression Therapeutics competitors?

      Competitors of Expression Therapeutics include Neogene Therapeutics, Instil Bio and Paragon Gene Therapy.

    • Where is Expression Therapeutics headquarters?

      Expression Therapeutics headquarters is located at 1860 Montreal Rd, Tucker.

    • Where are Expression Therapeutics offices?

      Expression Therapeutics has an office in Tucker.

    • How many offices does Expression Therapeutics have?

      Expression Therapeutics has 1 office.